In clinical trials for FDA-approved branded versions, tirzepatide produced stronger average weight-loss outcomes in head-to-head data
However, consistent dosing every week produces the best results for sustained weight management
People with type 2 diabetes , high blood pressure, high cholesterol, obstructive sleep apnea, smoking, and certain optic nerve anatomical features are known to have a higher risk of developing the condition (2 Trusted Source Ischemic Optic Neuropathies Go to source)
Localized telogen effluvium following hair transplantation
In recently published articles, orforglipron demonstrated robust efficacy without strict control of the prandial state at the time of dosing [26, 27]
What happens if I'm not losing weight as fast as expected